AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ANIMALCARE GROUP PLC

Management Reports Jan 3, 2013

7488_rns_2013-01-03_17164ffe-57b0-42fe-938e-c29c47ed48ea.html

Management Reports

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7096U

Animalcare Group PLC

03 January 2013

Animalcare Group plc

("Animalcare")

Sale of Buprecare ampoules resumed

Animalcare Group plc (AIM: ANCR), a leading supplier of veterinary medicines, is pleased to announce that the sale of Buprecare single dose ampoules has resumed following the break in supply announced in July 2011.

Animalcare received notification from its previous supplier of Buprecare single dose ampoules, the contract manufacturing group Recipharm, in July 2011 that they would be closing their sterile injectable production unit with immediate effect. This resulted in the immediate supply disruption of ampoule product to the UK and European markets.

A new contract has been signed with a German multinational contract manufacturer with a substantial sterile injectables facility in France and that facility has now been approved to manufacture Buprecare single dose ampoules.  Buprecare single dose ampoules from the new supplier are now available for sale in all previously supplied markets in the UK and Europe.

Animalcare management is confident about the new supply of Buprecare ampoules and is also confident that levels of sales similar to those prior to the supply disruption will be reached. The Company is now focusing on bringing the product back to market.

Buprecare multidose vial, an analgesic for cats and dogs launched in March 2012, continues to sell well. Its strong performance is expected to complement the sale of the ampoule product.

Stephen Wildridge, CEO of Animalcare Group plc, commented:  "It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly however after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position.  It's a very good way to start 2013."

Animalcare Group plc
Stephen Wildridge (Chief Executive Officer) Tel: 01904 487 601
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell/Richard Lindley Tel: 020 7496 3000
Walbrook PR Ltd Tel: 020 7933 8780
Paul McManus [email protected]
Helen Westaway [email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFSRLIIFIIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.